How we work
With a very well established infrastructure and processes, Mendelics has consolidated a quality management system focused on meeting international quality standards, audited on a yearly basis by nationally and internationally recognized entities.
Mission
To make genetic diagnosis fast, accurate, and accessible to everyone who needs it.
Vision
To be one of the main world references in genomic diagnosis and interpretation.
Values
Ethics, seriousness, honesty, reliability, commitment, dedication, accessibility, precision, efficiency, innovation.
Our History
Established in 2012, Mendelics is the first and largest Brazilian laboratory specialized in genetic diagnosis tests for rare diseases and cancer through the Next Generation Sequencing (NGS) technique.
We’re pioneers and leaders in Next Generation Sequencing (NGS) in Latin America, being the only Latin American genomic base laboratory to obtain accreditations from CAP (College of American Pathologists – No. 8671464), PALC (Program for Accreditation of Clinical Laboratories – # 11778564) and INMETRO in NBR/ISO-15189.
Awarded Platform
Mendelics was granted with the MIT award for innovation with Abracadabra®, a platform developed in-house to analyze the sequencing results of our patients’ samples.
By using artificial intelligence, Abracadabra® analyzes the genetic variants found in the samples and classify them according to their clinical relevance (from benign to pathogenic).
The analyses in Abracadabra® are exclusively carried out by geneticist physicians and other genomics analysis specialists, who are also responsible for elaborating the reports.
Board of Directors
Dr. David Schlesinger
CEO
- Clinical Neurologist, Ph.D. in Human Genetics from the University of São Paulo (USP)
- Undergraduate degree in Medicine from the University of São Paulo (USP)
Dr. André Valim
BUSINESS DIRECTOR
- Residency in Psychiatry at USP’s HC
- Undergraduate degree in Medicine from the University of São Paulo (USP)
Dr. João Paulo Kitajima
BIOINFORMATICS DIRECTOR
- Ph.D. in Computer Sciences from the Univ. Grenoble
- Post-doctorate degree in Bioinformatics at UNICAMP
- Doctorate degree in Informatique from the Institut National Polytechique de Grenoble, INPG in France
- Master’s degree in Computer Science from the UFRGS
- Undergraduate degree in Data Processing Technology from the UnB
Prof. Dr. Fernando Kok
MEDICAL DIRECTOR
- Full Professor of Pediatric Neurology at University of São Paulo (USP)
- Post-doctorate degree in Neurogenetics at Johns Hopkins University
- Doctorate degree in Neurology from the University of São Paulo (USP)
- Residency in Pediatric Neurology at USP’s HC
- Undergraduate degree in Medicine by USP
In the Media
Technology Innovation
By using artificial intelligence and assistance provided by Abracadabra, outside of the United States, Mendelics is currently considered as being the main submitter of genetic variants of ClinVar, the largest international database for the publication of human genetic variants.
Pioneer in Next Generation Sequencing (NGS) in Latin America
Mendelics’ laboratory has the largest sample processing capacity of Latin America, being capable of analyzing more than 10 thousand whole exome sequencing per month.
Mendelics’ Accreditations
Laboratory accreditations contribute with information which allows patients and physicians to evaluate if a laboratory presents technical competence, reliable results and reasonable costs.
Latest Technical Articles and Materials
A Breast Cancer Polygenic Risk Score Validation in 15,490 Brazilians using Exome Sequencing
Continuar LendoNovel ERLIN2 variant expands the phenotype of Spastic Paraplegia 18
Continuar LendoData security
At Mendelics, we use robust information security measures when processing your data, in accordance with best market practices and LGPD.
Also check out our Privacy Policy on the processing of personal data.
